Tumoral calcinosis is an unusual metabolic complication that is uncommonly seen in chronic dialysis patients with deranged calcium and phosphate metabolism. We report a case that was resistant to medical and surgical treatment, which eventually led to septicemic shock and death. This case highlighted to importance of routine surveillance with radiographic and physical examination of musculoskeletal system in high-risked susceptible dialysis patients, even in the absence of warning signs and symptoms.
A 42 year old Malay gentleman presented with nonspecific joint pain seven years after starting haemodialysis (HD] . He was known to be noncompliant with medical treatment and frequently had high serum calcium (>2.5 mmol/l), phosphate (>3.0 mmol/l) and iPTH levels (>250pg/L) in his routine blood reviews.
Ultrasonogram confirmed parathyroid hyperplasia consistent with secondary hyperparathyroidism. Further radiological examinations including X-rays and CT scans showed calcified masses in the soft tissues over his left hip and knee joints with no bony involvement. The left hip mass was subsequently surgically excised and he underwent subtotal parathyroidectomy in 2007. He experienced relief in his symptoms for a few years but was not attending medical follow up on a consistent basis.
Four years after the initial left hip surgery, he continued to have swelling over the excised area with additional ones over the left shoulder, right hip, right knee and thighs. The left groin swelling (Figure 1) was painful, tender and fluctuant with no skin changes.
Ultrasonogram showed multiple loculated fluid-filled and hard calcified lesions within the left hip area. Xrays confirmed the presence of calcified mass ( Figure  3 ) which was more extensive than four years earlier. The fluid analysis showed calcium spirules with few inflammatory giant cells. There was no pus or tumour cells and the culture grew no organism. A diagnosis of tumoral calcinosis was made based on these findings and the absence of other known metabolic and systemic disease. As the lesion was too large and the patient was not physically fit, complete surgical resection of the lesion was not thought to be feasible. As a result, multiple needle aspirations were attempted for palliative purposes to relieve pain and improve mobility. The serum calcium and phosphate level were between 2.35 to 2.50 mmol and 2.19 to 2.34 mmol respectively with persistently elevated calcium x phosphate products. His iPTH level was only mildly elevated (50-70pg/L) during this period. The patient had been treated with non-calcium based phosphate binders (sevelamer hydrochloride) and calcimietics (cinacalchet) for the past few years but unfortunately there was no significant improvement in his blood results. His treatment was escalated with sodium thiosulphate (25 grams per dialysis session), which was meant to be continued for six months. Unfortunately he succumbed to septicaemia from Methicillin-Resistant Staphylococcus Aureus after three months despite treatment with Vancomycin.
DISCUSSION
Tumoral calcinosis is originally described as an uncommon type of extraosseous calcification characterised by large rubbery or cystic masses containing calcium-phosphare deposits by Parfitt AM in 1969 [1] . However this condition has been described earlier in the European literature between 1930 and 1950, at which time it was known as Teutschlaender disease [2] . Renal-related tumoral calcinosis is an acquired variant and is usually termed uremic tumoral calcinosis (UTC). This diagnosis is usually heavily reliant on medical history, radiological and histological findings. The prevalence of UTC ranges between 0.5% and 3% in uremic patients on HD [3, 4] . Cases are however not limited to HD patients as several cases in the peritoneal dialysis population has been reported [5] . Other non-renal related causes including sarcoidosis [6, 7] , systemic sclerosis [8] , familial [9, 10] and idiopathic [11, 12] causes have also been described. In the idiopathic and familial form, in-born error of phosphorous metabolism has been postulated to be the main pathogenic factor. In chronic kidney disease patients with low turnover bone disease, calcium deposition in the skin and other extraosseus tissues may be favoured over bones hence triggering the development of tumoral calcinosis. Microtrauma of connective tissues around the joints, causing bleeding and the formation of rudimentary bursae leading to an eventual cascade of uncontrolled calcifications has been implicated in the pathogenesis of this condition [13] . However, the exact pathogenesis of the condition is still to be elucidated. UTC frequently presents as multinodular hard masses, although fluctuant, loculated and fluid filled variants are also occasionally described. The calcium deposition can occur in soft tissues in any joints but are more prevalent in weight-bearing and easily overused joints such as shoulders, elbows and hips [14] . The condition per se rarely induces pain unless there is a mass effect of the lesion [5] . We understood that our patient present late with his complications because he was non-compliant with his treatment and was not affected by pain. He did not seek medical attention until he was debilitated by the mobility restricting effects of the lesion. His condition was diagnosed late partly because he has been rendered wheel-chair bound for many years after his initial presentation. This may have masked his sub-acute presentation of recurrent UTC.
Treatment for this condition is generally unsatisfactory. Phosphate-binding antaacids together with a diet low in calcium and phosphate have been used to lower intestinal absorption of phosphate and treat tumoral calcinosis [15] . Renal transplantation has been known to halt the progression of disease, presumably through the normalisation of the calciumphosphate metabolism [16, 17] . The use of sevelamer and carbonic anhydrase inhibitor acetazolamide has been shown to reduce the progression of disease in the familial form of tumoral calcinosis [18] , likely through limiting the exposure to calcium. Parathyroidectomy may also lead to rapid resolution of tumoral calcinosis, implicating the important role of PTH in disease pathogenesis [19] . Sodium thiosulphate which has a widely reported success with its efficacy in calciphylaxis has also been successfully used in the treatment of tumoral calcinosis in patients with ESRD [20] . Etidronate [21] and elcatonin [6] were also reported success in some case reports. Surgical excision and drainage offered short period of Symptom relief in some cases [23] . Our patient had the full benefit of medical and surgical treatment with calcium sparing phosphate binders, calcimimetics, parathyroidectomy and sodium thiosulphate but unfortunately, his disease was too advanced to derive significant benefits from the treatment. The presence of progressive disease despite moderately elevated iPTH and calcium-phosphate derangements suggested that calcium-phosphate homeostasis may not be the only factor driving the disease process. This view is consistent with that held by many that non-metabolic factors like sepsis, immobility and genetic predisposition may have roles in disease development and progression [2] .
We conclude that tumoral calcinosis is a metabolic complication seen in patients on long term dialysis, usually with uncontrolled calcium and phosphate metabolism. Some medical and surgical treatment has been reported to halt or slow the progression of disease. Many cases are often missed during the initial stages as histological and radiological confirmations are needed to confirm the presence of the disease. As the condition is commonly painless in the earlier stages, routine radiological and physical examination of commonly affected joints in vulnerable patients should be advocated to pick up the disease at an earlier stage. Treatment of advanced cases is usually palliative and rarely satisfactory.
